

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.94482747 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.54008765 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.19781040 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.19781040 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.75875084 |
| 6 | * actin nucleation (GO:0045010) | 4.71388375 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.52887543 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.42618293 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.40616549 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.26510864 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.20963761 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.17146339 |
| 13 | response to muramyl dipeptide (GO:0032495) | 4.12516695 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.05605727 |
| 15 | NIK/NF-kappaB signaling (GO:0038061) | 4.05202266 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.02015268 |
| 17 | positive regulation of B cell differentiation (GO:0045579) | 3.98080586 |
| 18 | thymic T cell selection (GO:0045061) | 3.88457999 |
| 19 | detection of bacterium (GO:0016045) | 3.87949030 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81579415 |
| 21 | response to peptidoglycan (GO:0032494) | 3.81350099 |
| 22 | negative thymic T cell selection (GO:0045060) | 3.68649955 |
| 23 | detection of other organism (GO:0098543) | 3.63708394 |
| 24 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.62784909 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 3.59621325 |
| 26 | negative T cell selection (GO:0043383) | 3.58052597 |
| 27 | T cell selection (GO:0045058) | 3.50189133 |
| 28 | mannose metabolic process (GO:0006013) | 3.44308997 |
| 29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.39048353 |
| 30 | leukocyte aggregation (GO:0070486) | 3.37783841 |
| 31 | regulation of B cell differentiation (GO:0045577) | 3.34736851 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.33962665 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.33962665 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 3.33962665 |
| 35 | positive regulation by symbiont of host defense response (GO:0052509) | 3.33962665 |
| 36 | modulation by symbiont of host defense response (GO:0052031) | 3.33962665 |
| 37 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.33962665 |
| 38 | positive T cell selection (GO:0043368) | 3.31883996 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 3.30718593 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.29930310 |
| 41 | germinal center formation (GO:0002467) | 3.28894543 |
| 42 | response to interleukin-15 (GO:0070672) | 3.28799577 |
| 43 | B cell receptor signaling pathway (GO:0050853) | 3.28325218 |
| 44 | tolerance induction (GO:0002507) | 3.26600647 |
| 45 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.18078110 |
| 46 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.18078110 |
| 47 | neutrophil activation (GO:0042119) | 3.17519971 |
| 48 | cellular response to interleukin-15 (GO:0071350) | 3.16347499 |
| 49 | granulocyte activation (GO:0036230) | 3.11550553 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.10649841 |
| 51 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.10188536 |
| 52 | Peyers patch development (GO:0048541) | 3.10188536 |
| 53 | negative regulation of innate immune response (GO:0045824) | 3.07328133 |
| 54 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06962870 |
| 55 | cellular response to type I interferon (GO:0071357) | 3.05390166 |
| 56 | type I interferon signaling pathway (GO:0060337) | 3.05390166 |
| 57 | response to type I interferon (GO:0034340) | 3.03916136 |
| 58 | positive regulation of granulocyte differentiation (GO:0030854) | 2.98252901 |
| 59 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.97140871 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 2.95913513 |
| 61 | regulation of antigen processing and presentation (GO:0002577) | 2.95485166 |
| 62 | defense response to protozoan (GO:0042832) | 2.93480544 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 2.90219834 |
| 64 | regulation of granulocyte differentiation (GO:0030852) | 2.87800720 |
| 65 | regulation of T cell tolerance induction (GO:0002664) | 2.87712030 |
| 66 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.87570994 |
| 67 | macrophage activation involved in immune response (GO:0002281) | 2.86396858 |
| 68 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84884990 |
| 69 | T cell migration (GO:0072678) | 2.84026335 |
| 70 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.82869112 |
| 71 | negative regulation of T cell mediated immunity (GO:0002710) | 2.79354283 |
| 72 | respiratory burst (GO:0045730) | 2.78129535 |
| 73 | response to protozoan (GO:0001562) | 2.75784018 |
| 74 | detection of external biotic stimulus (GO:0098581) | 2.74053151 |
| 75 | regulation of regulatory T cell differentiation (GO:0045589) | 2.72032215 |
| 76 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.70343170 |
| 77 | regulation of ARF GTPase activity (GO:0032312) | 2.67386727 |
| 78 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.65895043 |
| 79 | N-acetylneuraminate metabolic process (GO:0006054) | 2.65378049 |
| 80 | regulation of leukocyte degranulation (GO:0043300) | 2.61333130 |
| 81 | negative regulation of granulocyte differentiation (GO:0030853) | 2.59656395 |
| 82 | regulation of tolerance induction (GO:0002643) | 2.59148328 |
| 83 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.57661564 |
| 84 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.57275321 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 2.55794748 |
| 86 | natural killer cell differentiation (GO:0001779) | 2.55716299 |
| 87 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.53680765 |
| 88 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.53174244 |
| 89 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.52843737 |
| 90 | modulation by virus of host process (GO:0019054) | 2.52753114 |
| 91 | T cell receptor signaling pathway (GO:0050852) | 2.51955283 |
| 92 | myeloid dendritic cell activation (GO:0001773) | 2.51946513 |
| 93 | regulation of monocyte differentiation (GO:0045655) | 2.51890372 |
| 94 | detection of biotic stimulus (GO:0009595) | 2.51615672 |
| 95 | leukocyte degranulation (GO:0043299) | 2.51538267 |
| 96 | * retrograde transport, endosome to Golgi (GO:0042147) | 2.50869486 |
| 97 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.50840813 |
| 98 | myeloid dendritic cell differentiation (GO:0043011) | 2.50141166 |
| 99 | regulation of interleukin-2 production (GO:0032663) | 2.49828445 |
| 100 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.49605990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.22880249 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.06715171 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 2.85383227 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.50258564 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.49894464 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.49043452 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42646666 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.30809849 |
| 9 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.29102988 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.22736688 |
| 11 | MAF_26560356_Chip-Seq_TH1_Human | 2.22685189 |
| 12 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.20517164 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.18054956 |
| 14 | * MAF_26560356_Chip-Seq_TH2_Human | 2.12494985 |
| 15 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.12102717 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.11036868 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.09644217 |
| 18 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.09419912 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.04465823 |
| 20 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03055910 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02602280 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00250176 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.98142982 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94158029 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.94125159 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92111437 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88411510 |
| 28 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.86853648 |
| 29 | P68_20966046_ChIP-Seq_HELA_Human | 1.81847066 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.75819307 |
| 31 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.74539813 |
| 32 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.72578543 |
| 33 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.68233667 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66147673 |
| 35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65496399 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65386566 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64236623 |
| 38 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.64106361 |
| 39 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.57218638 |
| 40 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.55266589 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54889651 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.54313599 |
| 43 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.54155045 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.53039409 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49114280 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.48680926 |
| 47 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48617485 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.48217157 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44456962 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43202287 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.43176611 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42391373 |
| 53 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42036171 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40185624 |
| 55 | * MYB_26560356_Chip-Seq_TH1_Human | 1.39638973 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39108909 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36896687 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36520094 |
| 59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.36122794 |
| 60 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34858196 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33655263 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32348035 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31897577 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30819964 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30579569 |
| 66 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.30335004 |
| 67 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.30000721 |
| 68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29580765 |
| 69 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29295494 |
| 70 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27038901 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26604842 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26338594 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26335479 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25987307 |
| 75 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25940245 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25243028 |
| 77 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.24950393 |
| 78 | SA1_27219007_Chip-Seq_Bcells_Human | 1.24483460 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23581999 |
| 80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22600239 |
| 81 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21824747 |
| 82 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.21205630 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20811280 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19751242 |
| 85 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19653703 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18451641 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16718376 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16273492 |
| 89 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15614301 |
| 90 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15503762 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15115806 |
| 92 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14521525 |
| 93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13822557 |
| 94 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.13624157 |
| 95 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.13586094 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13545886 |
| 97 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.12867660 |
| 98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12126744 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08872233 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08768422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.12259518 |
| 2 | MP0005671_abnormal_response_to | 3.16005928 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.11869194 |
| 4 | MP0003724_increased_susceptibility_to | 2.96824953 |
| 5 | MP0003303_peritoneal_inflammation | 2.91931915 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.90397354 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.82140163 |
| 8 | MP0005025_abnormal_response_to | 2.71956225 |
| 9 | MP0005387_immune_system_phenotype | 2.69523876 |
| 10 | MP0001790_abnormal_immune_system | 2.69523876 |
| 11 | MP0001800_abnormal_humoral_immune | 2.68018725 |
| 12 | MP0009278_abnormal_bone_marrow | 2.67377910 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.66232483 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.65865809 |
| 15 | MP0000685_abnormal_immune_system | 2.62528894 |
| 16 | MP0002419_abnormal_innate_immunity | 2.58104232 |
| 17 | MP0002723_abnormal_immune_serum | 2.54806874 |
| 18 | MP0009785_altered_susceptibility_to | 2.49994120 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.44465418 |
| 20 | MP0001819_abnormal_immune_cell | 2.42018142 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.38931966 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.32091026 |
| 23 | MP0004947_skin_inflammation | 2.23393216 |
| 24 | MP0008260_abnormal_autophagy | 2.19632961 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.16577371 |
| 26 | MP0002398_abnormal_bone_marrow | 2.10280479 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.01170038 |
| 28 | MP0002405_respiratory_system_inflammati | 1.97098779 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.96791228 |
| 30 | MP0000716_abnormal_immune_system | 1.95122994 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.93215099 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.93215099 |
| 33 | MP0006082_CNS_inflammation | 1.89560863 |
| 34 | MP0001873_stomach_inflammation | 1.82436374 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.81860956 |
| 36 | MP0005451_abnormal_body_composition | 1.71312342 |
| 37 | MP0002722_abnormal_immune_system | 1.69499590 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.68296168 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.68090011 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.66845371 |
| 41 | MP0002429_abnormal_blood_cell | 1.64413225 |
| 42 | MP0003866_abnormal_defecation | 1.62965726 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.62224900 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.62007277 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.59354368 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.53717340 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.51644911 |
| 48 | MP0009840_abnormal_foam_cell | 1.45736120 |
| 49 | MP0000858_altered_metastatic_potential | 1.42559042 |
| 50 | MP0002933_joint_inflammation | 1.40509793 |
| 51 | MP0001853_heart_inflammation | 1.40101691 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.35078041 |
| 53 | MP0009764_decreased_sensitivity_to | 1.33148628 |
| 54 | MP0008469_abnormal_protein_level | 1.32684718 |
| 55 | MP0004510_myositis | 1.30204896 |
| 56 | MP0005083_abnormal_biliary_tract | 1.28647041 |
| 57 | MP0004381_abnormal_hair_follicle | 1.25434698 |
| 58 | MP0000604_amyloidosis | 1.21102464 |
| 59 | MP0003329_amyloid_beta_deposits | 1.13423925 |
| 60 | MP0005310_abnormal_salivary_gland | 1.12360053 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.11662218 |
| 62 | MP0002132_abnormal_respiratory_system | 1.04414873 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.03734215 |
| 64 | MP0004858_abnormal_nervous_system | 0.95366688 |
| 65 | MP0003075_altered_response_to | 0.94919848 |
| 66 | MP0005390_skeleton_phenotype | 0.88154110 |
| 67 | MP0009765_abnormal_xenobiotic_induced | 0.85531511 |
| 68 | MP0001663_abnormal_digestive_system | 0.84533352 |
| 69 | MP0002166_altered_tumor_susceptibility | 0.83066451 |
| 70 | MP0000343_altered_response_to | 0.82852535 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.81736608 |
| 72 | MP0009763_increased_sensitivity_to | 0.79713638 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 0.79538665 |
| 74 | MP0000678_abnormal_parathyroid_gland | 0.78614263 |
| 75 | MP0001986_abnormal_taste_sensitivity | 0.78174173 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.76763793 |
| 77 | MP0000490_abnormal_crypts_of | 0.76460665 |
| 78 | MP0002009_preneoplasia | 0.76288976 |
| 79 | MP0003690_abnormal_glial_cell | 0.75745242 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.75404661 |
| 81 | MP0003795_abnormal_bone_structure | 0.73899773 |
| 82 | MP0008874_decreased_physiological_sensi | 0.73777641 |
| 83 | MP0003828_pulmonary_edema | 0.72599782 |
| 84 | MP0005535_abnormal_body_temperature | 0.71761946 |
| 85 | MP0008995_early_reproductive_senescence | 0.71725731 |
| 86 | MP0001851_eye_inflammation | 0.70589093 |
| 87 | MP0000681_abnormal_thyroid_gland | 0.68805099 |
| 88 | MP0005166_decreased_susceptibility_to | 0.67807035 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.67749346 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 0.63620983 |
| 91 | MP0001849_ear_inflammation | 0.62864859 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.61669605 |
| 93 | MP0009931_abnormal_skin_appearance | 0.55233970 |
| 94 | MP0000609_abnormal_liver_physiology | 0.54282844 |
| 95 | MP0003879_abnormal_hair_cell | 0.54248121 |
| 96 | MP0003448_altered_tumor_morphology | 0.53521054 |
| 97 | MP0005381_digestive/alimentary_phenotyp | 0.52178405 |
| 98 | MP0003045_fibrosis | 0.51193117 |
| 99 | MP0000249_abnormal_blood_vessel | 0.50932897 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.50853982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.83078581 |
| 2 | Chronic obstructive pulmonary disease (HP:0006510) | 4.07339047 |
| 3 | Obstructive lung disease (HP:0006536) | 4.07339047 |
| 4 | Myositis (HP:0100614) | 4.06001295 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.04043149 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.03615677 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.01180384 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.99616851 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 3.72919519 |
| 10 | Stomatitis (HP:0010280) | 3.54978978 |
| 11 | Meningitis (HP:0001287) | 3.42019065 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.33076251 |
| 13 | Increased IgE level (HP:0003212) | 3.25087785 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.24203357 |
| 15 | Orchitis (HP:0100796) | 3.22363101 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.13118796 |
| 17 | Pustule (HP:0200039) | 3.04320911 |
| 18 | Gastrointestinal inflammation (HP:0004386) | 3.02583664 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.02106919 |
| 20 | Hypertensive crisis (HP:0100735) | 2.99373045 |
| 21 | Colitis (HP:0002583) | 2.95373764 |
| 22 | Prolonged bleeding time (HP:0003010) | 2.94768951 |
| 23 | Dysostosis multiplex (HP:0000943) | 2.94556325 |
| 24 | Vasculitis (HP:0002633) | 2.92674179 |
| 25 | Granulocytopenia (HP:0001913) | 2.90338674 |
| 26 | Inflammation of the large intestine (HP:0002037) | 2.89608982 |
| 27 | Optic neuritis (HP:0100653) | 2.86480018 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 2.86480018 |
| 29 | Increased IgM level (HP:0003496) | 2.85801048 |
| 30 | Recurrent skin infections (HP:0001581) | 2.85092365 |
| 31 | Recurrent viral infections (HP:0004429) | 2.75235596 |
| 32 | Encephalitis (HP:0002383) | 2.74462098 |
| 33 | Agammaglobulinemia (HP:0004432) | 2.74127150 |
| 34 | Purpura (HP:0000979) | 2.70376039 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 2.69099332 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.69099332 |
| 37 | Increased serum ferritin (HP:0003281) | 2.67832885 |
| 38 | Seborrheic dermatitis (HP:0001051) | 2.63346842 |
| 39 | Petechiae (HP:0000967) | 2.59842345 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59691160 |
| 41 | Reticulocytosis (HP:0001923) | 2.58435969 |
| 42 | Cellulitis (HP:0100658) | 2.57719090 |
| 43 | Severe combined immunodeficiency (HP:0004430) | 2.55614562 |
| 44 | Abnormal gallbladder physiology (HP:0012438) | 2.51033759 |
| 45 | Cholecystitis (HP:0001082) | 2.51033759 |
| 46 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47853388 |
| 47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47853388 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47853388 |
| 49 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.47834367 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.44277208 |
| 51 | Chest pain (HP:0100749) | 2.43578901 |
| 52 | Gastrointestinal stroma tumor (HP:0100723) | 2.41710759 |
| 53 | Epistaxis (HP:0000421) | 2.40023579 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.39464404 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.37610156 |
| 56 | Abnormality of T cells (HP:0002843) | 2.37139001 |
| 57 | Abnormality of lateral ventricle (HP:0030047) | 2.36851333 |
| 58 | IgG deficiency (HP:0004315) | 2.35733065 |
| 59 | Gingivitis (HP:0000230) | 2.35310341 |
| 60 | Autoimmune hemolytic anemia (HP:0001890) | 2.32030503 |
| 61 | Hemorrhage of the eye (HP:0011885) | 2.31712966 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.31624868 |
| 63 | T lymphocytopenia (HP:0005403) | 2.31160801 |
| 64 | Hypochromic anemia (HP:0001931) | 2.30892404 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.28502597 |
| 66 | Abnormality of iron homeostasis (HP:0011031) | 2.27709109 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24208834 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24208834 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24208834 |
| 70 | Myopathic facies (HP:0002058) | 2.23637444 |
| 71 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.23223356 |
| 72 | Leukocytosis (HP:0001974) | 2.20661712 |
| 73 | Combined immunodeficiency (HP:0005387) | 2.18851690 |
| 74 | J-shaped sella turcica (HP:0002680) | 2.18046527 |
| 75 | Lymphopenia (HP:0001888) | 2.16928066 |
| 76 | Abnormality of T cell physiology (HP:0011840) | 2.16140457 |
| 77 | Loss of speech (HP:0002371) | 2.14918943 |
| 78 | Hemoptysis (HP:0002105) | 2.14878409 |
| 79 | Abnormality of T cell number (HP:0011839) | 2.10700198 |
| 80 | Urticaria (HP:0001025) | 2.08865998 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.07643154 |
| 82 | Obstructive sleep apnea (HP:0002870) | 2.07360746 |
| 83 | Fatigue (HP:0012378) | 2.06962516 |
| 84 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.06694806 |
| 85 | Spontaneous hematomas (HP:0007420) | 2.05767573 |
| 86 | Mucopolysacchariduria (HP:0008155) | 2.05461261 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05461261 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.04008485 |
| 89 | Restrictive lung disease (HP:0002091) | 1.99251313 |
| 90 | Acute hepatic failure (HP:0006554) | 1.99082451 |
| 91 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96998588 |
| 92 | Premature loss of primary teeth (HP:0006323) | 1.96328266 |
| 93 | Emphysema (HP:0002097) | 1.95774208 |
| 94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91073751 |
| 95 | Episodic fever (HP:0001954) | 1.90797351 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.90369683 |
| 97 | Easy fatigability (HP:0003388) | 1.90324938 |
| 98 | Truncus arteriosus (HP:0001660) | 1.90014523 |
| 99 | Eosinophilia (HP:0001880) | 1.88395864 |
| 100 | Sepsis (HP:0100806) | 1.87888880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.71046811 |
| 2 | TAOK3 | 3.39695254 |
| 3 | RIPK4 | 3.37002265 |
| 4 | ERN1 | 2.99683327 |
| 5 | TXK | 2.60069149 |
| 6 | TNK2 | 2.51537708 |
| 7 | TRIB3 | 2.36451082 |
| 8 | GRK6 | 2.22377962 |
| 9 | PRPF4B | 2.20783147 |
| 10 | TBK1 | 2.08901588 |
| 11 | MAP2K3 | 2.04426689 |
| 12 | MAP3K11 | 2.03888839 |
| 13 | FES | 2.00457287 |
| 14 | TESK2 | 1.92148386 |
| 15 | MAP3K14 | 1.84584019 |
| 16 | SIK1 | 1.75384558 |
| 17 | ZAP70 | 1.70448794 |
| 18 | SIK2 | 1.67905689 |
| 19 | TYK2 | 1.67904931 |
| 20 | MAP3K13 | 1.66237922 |
| 21 | IRAK4 | 1.63987251 |
| 22 | BLK | 1.60018322 |
| 23 | BTK | 1.58083403 |
| 24 | SIK3 | 1.54956068 |
| 25 | NME2 | 1.51015911 |
| 26 | SYK | 1.46217563 |
| 27 | IKBKE | 1.44345533 |
| 28 | JAK3 | 1.43761295 |
| 29 | KDR | 1.41993574 |
| 30 | CSK | 1.39396122 |
| 31 | IRAK3 | 1.37896800 |
| 32 | TAOK1 | 1.33448043 |
| 33 | IKBKB | 1.31995105 |
| 34 | TAOK2 | 1.27937655 |
| 35 | EPHB1 | 1.19942365 |
| 36 | MAP2K2 | 1.15490768 |
| 37 | BCKDK | 1.15102832 |
| 38 | MARK2 | 1.12990186 |
| 39 | ITK | 1.07938420 |
| 40 | MAP3K7 | 1.07085215 |
| 41 | HCK | 1.04961738 |
| 42 | LYN | 1.02732113 |
| 43 | LCK | 1.01562662 |
| 44 | ICK | 1.01118701 |
| 45 | CSF1R | 1.00974499 |
| 46 | PRKD2 | 0.97051583 |
| 47 | MAPK12 | 0.96206424 |
| 48 | MAP3K3 | 0.93842935 |
| 49 | MAP3K1 | 0.93081162 |
| 50 | MAP2K6 | 0.90799477 |
| 51 | JAK2 | 0.90396209 |
| 52 | CDC42BPA | 0.86854302 |
| 53 | SMG1 | 0.84302766 |
| 54 | MAPK15 | 0.84079099 |
| 55 | KSR2 | 0.83516931 |
| 56 | MATK | 0.82550176 |
| 57 | BMX | 0.79495093 |
| 58 | CAMKK1 | 0.78830973 |
| 59 | PTK6 | 0.75212734 |
| 60 | TESK1 | 0.74940304 |
| 61 | FGR | 0.74635073 |
| 62 | MAPK11 | 0.74338989 |
| 63 | PKN2 | 0.72474371 |
| 64 | PIM2 | 0.71586584 |
| 65 | DYRK1B | 0.70316841 |
| 66 | RPS6KC1 | 0.69999710 |
| 67 | RPS6KL1 | 0.69999710 |
| 68 | MAPK7 | 0.69261757 |
| 69 | KIT | 0.67818487 |
| 70 | PDK1 | 0.67603445 |
| 71 | MAP3K6 | 0.64632146 |
| 72 | HIPK2 | 0.64489065 |
| 73 | PDPK1 | 0.63592676 |
| 74 | FGFR4 | 0.61346131 |
| 75 | CDK4 | 0.61283025 |
| 76 | TEC | 0.60393273 |
| 77 | JAK1 | 0.58538686 |
| 78 | RIPK1 | 0.57202886 |
| 79 | MARK3 | 0.56204327 |
| 80 | RPS6KA6 | 0.56198967 |
| 81 | EEF2K | 0.55169143 |
| 82 | FYN | 0.54733436 |
| 83 | RPS6KA2 | 0.54536004 |
| 84 | CHUK | 0.49281756 |
| 85 | PIM1 | 0.48702088 |
| 86 | MAPKAPK3 | 0.47758551 |
| 87 | LRRK2 | 0.46456744 |
| 88 | PRKCQ | 0.46043139 |
| 89 | MAPK4 | 0.45984858 |
| 90 | MAPK3 | 0.42353853 |
| 91 | BMPR2 | 0.40377123 |
| 92 | MAP3K10 | 0.38873811 |
| 93 | TYRO3 | 0.36800753 |
| 94 | CDK12 | 0.35995519 |
| 95 | MAPKAPK2 | 0.35687796 |
| 96 | GRK7 | 0.33432203 |
| 97 | RET | 0.32254430 |
| 98 | PAK6 | 0.31923458 |
| 99 | DAPK1 | 0.26309488 |
| 100 | RPS6KA1 | 0.25676821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.27590014 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.11640394 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.64127797 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.37102108 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31970145 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.24136377 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.16952170 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.10844508 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.10069439 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.09848705 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.09402700 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.04823411 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.00337991 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91479418 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.88838925 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83507796 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.76922500 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73170927 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72326240 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.67623836 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64086136 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62242925 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60552534 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.57642988 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.57525780 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52298208 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46402430 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.46346378 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.43776376 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43227231 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.35466341 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.32871819 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32647005 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32528003 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.32341441 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.31938776 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.31889419 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30334033 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28582388 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.27400474 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.24953131 |
| 42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.21418782 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14862498 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.10606342 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09776992 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.07759854 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07519923 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.04190629 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.03544927 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03066626 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.99135878 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 0.94422324 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94200629 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91614601 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91557490 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90781863 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.88932094 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80278312 |
| 59 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.80211084 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80065001 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 0.79691040 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.79512754 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78046807 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78037335 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72777992 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71873251 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71482664 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71180512 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70468310 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70467805 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68663663 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67364293 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66798276 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66383874 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59942031 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59658426 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59250582 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.58669932 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58262039 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58022804 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57620608 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53466759 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52735927 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52733314 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52400621 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50863919 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.47186257 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46229909 |
| 89 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.45796704 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45471811 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44774603 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44051028 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43707796 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41408109 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.40403531 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39596426 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39316372 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37632557 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36207659 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35615549 |

